KEZAR LIFE SCIENCES INC (KZR) Stock Income Statement
NASDAQ:KZR - Nasdaq - US49372L2097 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 7.00M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 89.14M | 112.24M | 71.16M | 54.66M | 42.95M | |||
| Research and Development | 65.74M | 85.70M | 51.01M | 38.94M | 30.98M | |||
| Selling, General, and Administrative Expenses | 23.39M | 26.54M | 20.15M | 15.72M | 11.97M | |||
| Operating Income | -89.14M | -105.24M | -71.16M | -54.66M | -42.95M | |||
| Interest Income/Expense | 6.87M | 9.55M | 2.92M | 30.00K | 1.21M | |||
| Non Recurring Items | -1.47M | -6.19M | N/A | N/A | N/A | |||
| Income Before Taxes | -83.74M | -101.87M | -68.24M | -54.63M | -41.74M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -83.74M | -101.87M | -68.24M | -54.63M | -41.74M | |||
| EBITDA | -88.09M | -104.17M | -70.14M | -53.15M | -41.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.49 | -14.04 | -1.01 | -1.04 | -0.95 | |||
| Non GAAP EPS | -11.25 | -1.41 | -1.01 | -1.03 | -0.97 | |||
| Statistics | ||||||||
| Profit Margin | N/A | -1455.29% | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | -1503.39% | N/A | N/A | N/A | |||
All data in USD